1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. India >
  6. Sun Pharma >
  7. M&A

Sun Pharma Mergers & Acquisitions

Sun Pharma M&A Summary

Sun Pharma has acquired 15 companies, including 2 in the last 5 years.

Sun Pharma’s largest acquisition to date was in 2014, when it acquired Ranbaxy Laboratories for $4.0B. Sun Pharma has acquired in 3 different US states, and 6 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity15
  • Total Sectors Invested 2
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 2

Sun Pharma

Sun Pharmaceuticals Industries Ltd.

Sun House Plot No. 201 B/1 Western Express Highway Goregaon (East),
Mumbai, 400063
India,
+91 22 4324 4324
www.sunpharma.com

All (15) Buy (15) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-03-09 Checkpoint · Life Science
Waltham, Massachusetts · www.checkpointtx.com

Checkpoint is a commercial-stage company focused on developing novel treatments for patients with solid tumor cancers. It has received approval from the U.S. Food & Drug Administration (FDA) for UNLOXCYT (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. Checkpoint is based in Waltham, Massachusetts.

Advisors: Alston & Bird , Locust Walk Partners 		355 Add-on Acquisition

Sun Pharma
Advisors: A&O Shearman , Barack Ferrazzano Kirschbaum & Nagelberg (BKFN)

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal